Piia Simonen Selected Research

Cholestanol (Coprostanol)

1/2017	Low Childhood Cholesterol Absorption Predisposes to Gallstone Disease: The Cardiovascular Risk in Young Finns Study.
1/2011	Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.
8/2010	Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study.
1/2004	Low synthesis and high absorption of cholesterol characterize type 1 diabetes.
2/2002	Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piia Simonen Research Topics

Disease

4	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 10/2013
4	Body Weight (Weight, Body) 09/2015 - 02/2002
4	Type 2 Diabetes Mellitus (MODY) 08/2010 - 02/2002
3	Obesity 04/2021 - 08/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 08/2010
3	Sarcoidosis (Schaumann Disease) 01/2018 - 11/2015
2	Overweight 04/2021 - 10/2013
2	Atherosclerosis 01/2020 - 11/2018
2	Dyslipidemias (Dyslipidemia) 11/2018 - 01/2016
2	Cholelithiasis 09/2018 - 01/2017
2	Gallstones (Gallstone) 09/2018 - 01/2017
2	Inflammation (Inflammations) 05/2016 - 12/2015
1	Carcinoid Tumor (Carcinoid) 01/2022
1	Carcinoid Heart Disease 01/2022
1	Atrial Heart Septal Defects (Atrial Septal Defect) 10/2020
1	Left Ventricular Dysfunction 01/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Frailty 12/2018
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Alcoholic Hepatitis 01/2018
1	Heart Arrest (Cardiac Arrest) 01/2017
1	Aortic Valve Stenosis (Aortic Stenosis) 12/2015
1	Hypercholesterolemia 09/2015
1	Hypertriglyceridemia 09/2015
1	Fatty Liver 01/2011
1	Non-alcoholic Fatty Liver Disease 01/2011
1	Insulin Resistance 08/2010
1	Glucose Intolerance 08/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2004
1	Diabetes Mellitus 01/2004
1	Weight Loss (Weight Reduction) 02/2002

Drug/Important Bio-Agent (IBA)

13	CholesterolIBA 04/2021 - 02/2002
8	SterolsIBA 12/2018 - 02/2002
8	Phytosterols (Plant Sterols)IBA 09/2018 - 02/2002
6	LDL CholesterolIBA 04/2021 - 01/2011
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2004
5	lathosterolIBA 12/2018 - 01/2004
5	Cholestanol (Coprostanol)IBA 01/2017 - 02/2002
4	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 02/2002
3	LipidsIBA 12/2018 - 01/2017
3	Triglycerides (Triacylglycerol)IBA 09/2015 - 02/2002
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2021 - 10/2013
2	plant stanol esterIBA 04/2021 - 01/2020
2	oxidized low density lipoproteinIBA 01/2020 - 01/2004
2	DesmosterolIBA 12/2018 - 01/2011
2	campesterolIBA 09/2018 - 01/2017
2	gamma-sitosterol (beta-sitosterol)IBA 01/2017 - 08/2010
2	HDL CholesterolIBA 09/2015 - 01/2004
2	Lipoproteins (Lipoprotein)IBA 01/2011 - 01/2004
1	SteroidsIBA 04/2021
1	Coloring Agents (Dyes)IBA 10/2020
1	EstersIBA 08/2020
1	GadoliniumIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 12/2018
1	Rapeseed OilIBA 01/2018
1	CollagenIBA 12/2015
1	ElastinIBA 12/2015
1	MargarineIBA 12/2015
1	N 30IBA 11/2015
1	VLDL LipoproteinsIBA 09/2015
1	HDL LipoproteinsIBA 09/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015
1	SqualeneIBA 04/2008
1	Streptozocin (Streptozotocin)FDA Link 01/2004
1	IDL Lipoproteins (Lipoprotein, IDL)IBA 01/2004
1	Sex Hormone-Binding GlobulinIBA 02/2002
1	Insulin (Novolin)FDA Link 02/2002

Therapy/Procedure

1	Diet Therapy (Therapy, Diet) 04/2021
1	Heart Transplantation (Grafting, Heart) 01/2019
1	Therapeutics 01/2018
1	Defibrillators (Defibrillator) 01/2018
1	Transportation of Patients 01/2017
1	Transplantation 11/2015